Table 2.
Factor | Classification | p value (DFS) | p value (OS) |
---|---|---|---|
Sex | Female | ||
Male | 0.9818 | 0.8802 | |
Age | <65 | ||
≥65 | 0.5093 | 0.8196 | |
Cancer location | Right | ||
Transverse | 0.2048 | 0.0534 | |
Descending | 0.2056 | 0.5503 | |
Sigmoid and rectosigmoid | 0.7813 | 0.9634 | |
Lymphovascular invasion | Negative | ||
Positive | 0.4643 | 0.2176 | |
Neural invasion | Negative | ||
Positive | 0.3234 | 0.6679 | |
Histology (differentiation ) | Well | ||
Moderately | 0.5575 | 0.9728 | |
Poorly | 0.9001 | 0.894 | |
Signet ring cell | 0.1424 | 0.1516 | |
Mucinous cell | 0.8841 | 0.8773 | |
WBC | 4,000 ~ 10,000 × 106/L | ||
<4,000 × 106/L | 0.8888 | 0.9328 | |
Hgb | Normal | ||
Anemia | 0.0019 | 0.0143 | |
PLT | 140 ~ 440 × 109/L | ||
Thrombocytopenia | 0.0444 | 0.0485 | |
>440 × 109/L | 0.6451 | 0.7521 | |
Albumin | 3.8 ~ 5.3 g/dL | ||
<3.8 g/dL | 0.3055 | 0.0298 | |
LDH | 129 ~ 240 U/L | ||
>240 U/L | 0.1801 | 0.2756 | |
Total bilirubin | 0.2 ~ 1.0 mg/dL | ||
>1.0 mg/dL | 0.2247 | 0.8442 | |
AST | 10 ~ 33 U/L | ||
>33 U/L | 0.1258 | 0.4506 | |
ALT | 4 ~ 50 U/L | ||
>50 U/L | 0.4121 | 0.7752 | |
Protein | 6.7 ~ 8.3 g/dL | ||
<6.7 g/dL | 0.3451 | 0.3746 | |
T stage | 1 | ||
2 | |||
3 | |||
4 | 0.0018 | 0.005 | |
N stage | 0 | ||
1 | 0.2954 | 0.4345 | |
2 | 0.6658 | 0.1171 | |
Preoperative CEA | ≤5 ng/mL | ||
>5 ng/mL | 0.4768 | 0.2144 | |
Postoperative CEA | ≤5 ng/mL | ||
>5 ng/mL | 0.0585 | 0.0019 | |
ASA score | 1 | ||
2 | 0.31 | 0.7768 | |
3 | 0.7646 | 0 | |
Neutropenia | Absent | ||
Present | 0.7597 | 0.1927 | |
GI Symptom (diarrhea, nausea, anorexia) | Absent | ||
Present | 0.6714 | 0.508 |
ALT, alanine aminotransferase; ASA, American Society of Anesthesiologists; AST, aspartate aminotransferase; CEA, carcinoembryonic antigen; GI symptoms, gastrointestinal symptoms (diarrhea, constipation, anorexia); Hgb, hemoglobin; LDH, lactate dehydrogenase; PLT, platelet; WBC, white blood cell.